Head of Investor Relations
Lisata Therapeutics, Inc. (LSTA)Equibles does not estimate personal net worth.
Get an email with a short summary when Lisata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LSTA alertsJohn Menditto is recorded as Head of Investor Relations at Lisata Therapeutics, Inc. (LSTA). John Menditto has spoken on 19 earnings calls across 1 company, most recently for Lisata Therapeutics, Inc. on November 6, 2025. Lisata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lisata Therapeutics, Inc. includes David J. Mazzo (CEO and Board Member), David J. Mazzo, Ph.D. (CEO), Gregory Brown (Chairman) and 7 others.
“Welcome to Lasata's third quarter 2025 conference call to discuss our financial results and to provide a business update.”
“Welcome to Lisata's Third Quarter 2024 conference call to discuss our financial results and to provide a business update.”
“Welcome to Lisata's second quarter 2024 conference call to discuss our financial results and to provide a business update.”
“Welcome to Lisata's First Quarter 2024 Conference Call to discuss our financial results and to provide a business update.”
“Welcome to Lisata's Full Year 2023 Conference Call to discuss our financial results and provide a business update.”
Biotechnology · Healthcare
Head of Investor Relations
